Sustainability of the Achieving Clinical Audits with Electronic Records (ACAER) Asthma and COPD Quality Improvement Program on Patient Outcomes

Study identification

• EU PAS number:
  EUPAS1000000426
• Study ID:
  1000000426
• Official title and acronym:
  Sustainability of the Achieving Clinical Audits with Electronic Records (ACAER) Asthma and COPD Quality Improvement Program on Patient Outcomes
• DARWIN EU® study:
  No
• Study countries:
  Australia
• Study description:
  This project focuses on preventing high cost/high burden respiratory events through the harnessing, coordination, dissemination and scaling up of an evidence-based clinical audit model (ACAER Quality improvement program) into general practice. It aligns with national strategies for quality improvement in general practice, hence utilised current general practice infrastructure. ; ; The real-world effectiveness and sustainability of the ACAER QI program in supporting primary care providers in quality improvement initiatives across asthma and COPD care was assessed. Impact was evaluated based on changes in maintenance treatment and exacerbation rates.
• Study status:
  Planned

Research institutions and networks

Institutions

Optimum Patient Care Australia

Australia

The Woolcock Institute of Medical Research

Networks

Optimum Patient Care (OPC) Network

United Kingdom (Northern Ireland)

Respiratory Effectiveness Group (REG)

Belgium

Denmark

France

Germany

Greece

Hungary

Italy

Netherlands

Spain

Sweden

United Kingdom

Study timelines

Date when funding contract was signed

Planned:18/11/2020

Study start date

Planned:26/05/2021

Date of final study report

Planned:08/01/2024

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

Funding for this study was partially provided by Optimum Patient Care Australia and GlaxoSmithKline (GSK).

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable